central nervous system tumors
Showing 1 - 25 of >10,000
Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)
Recruiting
- Advanced Solid Tumors Harboring NTRK Fusion
- Primary Central Nervous System Tumors Harboring NTRK Fusion
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Feb 16, 2023
CNS Tumors Trial in Beijing (OH2 injection)
Recruiting
- Central Nervous System Tumors
- OH2 injection
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Feb 2, 2023
Radiation Therapy in Pediatric Central Nervous System Tumors
Completed
- Diffuse Intrinsic Pontine Glioma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)
Not yet recruiting
- Nervous System Tumor
- Administration of Indocyanine Green (ICG) and Visualization of Tumor
- (no location specified)
Feb 17, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)
Terminated
- Glioblastoma Multiforme
- +3 more
-
Indianapolis, IndianaRiley Hospital for Children at IU Health
Jul 21, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Malignant Brain Tumor, Glioma, Coping Skills Trial in Boston (Psychosocial intervention, Usual supportive care)
Not yet recruiting
- Malignant Brain Tumor
- +3 more
- Psychosocial intervention
- Usual supportive care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 19, 2023
CNS Qualitative Interview
Recruiting
- Central Nervous System Cancer
- Qualitative Interviews
-
Aurora, ColoradoChildren's Hospital Colorado
Oct 31, 2022
Central Nervous System Tumors Receiving Proton Beam Radiation
Recruiting
- Central Nervous System
- NIH Toolbox Cognitive Battery
-
Saint Louis, MissouriWashington University School of Medicine
Apr 21, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Exercise, CNS Tumors, Tumors Trial in Houston (Focus Groups, Pilot randomized controlled trial)
Recruiting
- Exercise
- +2 more
- Focus Groups
- Pilot randomized controlled trial
-
Houston, TexasM D Anderson Cancer Center
May 10, 2022
Clinical, Radiological, Histologic and Molecular Features
Recruiting
- Meningeal Melanocytoma
- +3 more
-
Nancy, FranceNancy University Hospital Center
Jul 31, 2023
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Suspected CNS Tumors Trial in Philadelphia (Indocyanine Green (ICG), Intraoperative near-infrared (NIR))
Completed
- Suspected Central Nervous System Tumors
- Indocyanine Green (ICG)
- Intraoperative near-infrared (NIR)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Sep 30, 2021
After Proton RT for Pediatric Tumors of Brain, Head, and Neck
Completed
- Central Nervous System Tumors
-
Jacksonville, FloridaUniversity of Florida Proton Therapy Institute
Jun 9, 2022
Pediatric CNS Tumor Trial in United States (tozuleristide, Canvas System)
Completed
- Pediatric Central Nervous System Tumor
- tozuleristide
- Canvas System
-
Los Angeles, California
- +8 more
Nov 9, 2022
Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- GDC-0084
- radiation therapy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 13, 2023
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022